Jiping Wang
- Hepatology top 2%
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research 12
- Cancer Research top 5%
- Cancer Genomics and Diagnostics 9
-
- Gastric Cancer Management and Outcomes 21
- Metastasis and carcinoma case studies 9
- Sarcoma Diagnosis and Treatment 8
- Gastroenterology top 5%
-
- Estrogen and related hormone effects 18
-
- Antibiotic Resistance in Bacteria 10
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 8
- Co-authors
- Wei YueRichard J. SantenMonica M. BertagnolliGeorge Z. LiMark FairweatherGerard M. DohertyMerril T. DaytonMahmoud N. Kulaylat
- Cited by
- HepatologyOncologyCancer Research
- Journals
- Annals of Surgical Oncology (12 papers)Clinical Cancer Research (7 papers)Journal of Clinical Oncology (6 papers)
- Partner nations
- United StatesChinaAustralia
In The Last Decade
Jiping Wang
132 papers receiving 4.0k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Hepatology 532
- Oncology 1.5k
- Cancer Research 588
- Pulmonary and Respiratory Medicine 1.2k
- Gastroenterology 163
Countries citing papers authored by Jiping Wang
This map shows the geographic impact of Jiping Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiping Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiping Wang more than expected).
Fields of papers citing papers by Jiping Wang
This network shows the impact of papers produced by Jiping Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiping Wang. The network helps show where Jiping Wang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jiping Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 4 | |
| 4 | 2023 | 2 | |
| 5 | 2023 | 2 | |
| 6 | Lenvatinib Combined With Transarterial Chemoembolization as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Phase III, Randomized Clinical Trial (LAUNCH)breakdown → | 2022 | 262 |
| 7 | 2021 | 17 | |
| 8 | 2021 | 2 | |
| 9 | 2021 | 8 | |
| 10 | PIF1 Affects the Proliferation and Apoptosis of Cervical Cancer Cells by Influencing TERT | 2020 | 1 |
| 11 | LncRNA PVT1 Enhances Proliferation and Cisplatin Resistance via Regulating miR-194-5p/HIF1a Axis in Oral Squamous Cell Carcinoma | 2020 | 2 |
| 12 | 2019 | 6 | |
| 13 | 2018 | 204 | |
| 14 | 2017 | 17 | |
| 15 | 2017 | 18 | |
| 16 | 2017 | 15 | |
| 17 | 2015 | 46 | |
| 18 | 2014 | 118 | |
| 19 | 2013 | 8 | |
| 20 | 2007 | 30 |
About Jiping Wang
Jiping Wang is a scholar working on Molecular Medicine, Oncology, Cancer Research, Gastroenterology and Pulmonary and Respiratory Medicine, having authored 141 papers that have together received 4.1k indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (21 papers), Estrogen and related hormone effects (18 papers), Pancreatic and Hepatic Oncology Research (12 papers), Antibiotic Resistance in Bacteria (10 papers), Cancer Genomics and Diagnostics (9 papers), Metastasis and carcinoma case studies (9 papers), Sarcoma Diagnosis and Treatment (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (8 papers). The work is most often cited by research in Hepatology (532 citations), Oncology (1.5k citations), Cancer Research (588 citations), Pulmonary and Respiratory Medicine (1.2k citations) and Gastroenterology (163 citations). Jiping Wang has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Wei Yue, Richard J. Santen, Monica M. Bertagnolli, George Z. Li, Mark Fairweather, Gerard M. Doherty, Merril T. Dayton, Mahmoud N. Kulaylat, James M. Hassett and Chandrajit P. Raut. Their work appears in journals such as Annals of Surgical Oncology, Clinical Cancer Research, Journal of Clinical Oncology, Antimicrobial Agents and Chemotherapy and Journal of Surgical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.